Cargando…
Randomized placebo-controlled trial of oral tannin supplementation on COVID-19 symptoms, gut dysbiosis and cytokine response
The clinical study aim was to investigate whether a tannin-based dietary supplementation could improve the efficacy of standard-of-care treatment of hospitalized COVID-19 patients by restoring gut microbiota function. Adverse events and immunomodulation post-tannin supplementation were also investig...
Autores principales: | Molino, Silvia, Pisarevsky, Andrea, Badu, Shyam, Wu, Qinglong, Mingorance, Fabiana López, Vega, Patricia, Stefanolo, Juan Pablo, Repetti, Julieta, Ludueña, Guillermina, Pepa, Pablo, Olmos, Juan Ignacio, Fermepin, Marcelo Rodriguez, Uehara, Tatiana, Viciani, Elisa, Castagnetti, Andrea, Savidge, Tor, Piskorz, María Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708634/ https://www.ncbi.nlm.nih.gov/pubmed/36467850 http://dx.doi.org/10.1016/j.jff.2022.105356 |
Ejemplares similares
-
Natural tannin extracts supplementation for COVID-19 patients (TanCOVID): a structured summary of a study protocol for a randomized controlled trial
por: Molino, Silvia, et al.
Publicado: (2021) -
Fr578 ORAL TANNINS REDUCE PROINFLAMMATORY CYTOKINES ASSOCIATED WITH DIARRHEA AND PNEUMONIA IN HOSPITALIZED COVID-19 PATIENTS.
por: Pisarevsky, Ana A., et al.
Publicado: (2021) -
EP1192: LIVER TEST ABNORMALITIES IN COVID-19 PATIENTS MAY NOT BE RELATED TO CYTOKINE STORM
por: Piskorz, Maria, et al.
Publicado: (2022) -
Su093 GUT-BRAIN AXIS AND IRRITABLE BOWEL SYNDROME DURING SARS COV-2 PANDEMIC. A SURVEY BASED STUDY.
por: Piskorz, Maria, et al.
Publicado: (2021) -
Changes in the Fecal Microbiota Associated with a Broad-Spectrum Antimicrobial Administration in Hospitalized Neonatal Foals with Probiotics Supplementation
por: Freccero, Francesca, et al.
Publicado: (2021)